- Cello Group reports good trading for the first six months to 30 June, with strong headline revenue growth.

But it says half year operating profits will be a little lower than last year due to anticipated short term profit variance at the Signal division as indicated with the AGM statement of 12 May. Based on current income pipelines the board is confident that current full year market expectations will be met.

Cello chief executive Mark Scott said: "The Group is making pleasing progress in its strategy of evolving into a global healthcare player. The transition to a more digital proposition for Cello Health has begun to create close and productive bonds between Cello Health and Signal which we will build on quickly to create further value for shareholders".

The group will announce its interim results on 16 September.

Story provided by